The Wearable Drug Delivery Devices Market was valued at USD 18.25 billion in 2023 and is projected to reach USD 34.10 billion by 2032, growing at a CAGR of 7.19% during the forecast period 2024-2032. This rapid market growth is driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, alongside technological advancements and increasing demand for patient-centric, non-invasive drug delivery solutions.